Clinical Research

The central illustration from a study that shows the impact of ECG AI algorithm study case and control selection to train artificial intelligence to better screening patients for cardiac amyloidosis. Image courtesy of JACC Advances.

Using ECG AI to find the cardiac amyloidosis needles in the haystack

Early detection of cardiac amyloidosis is leads to the best outcomes, but it is often missed until later stages. AI is being developed to help detect these patients earlier using ECG and echo.

Thumbnail

Even moderate alcohol use increases risk of high blood pressure, new meta-analysis confirms

Researchers explored data from 23 different studies, identifying a “positive and almost linear association” between alcohol consumption and hypertension. 

Paul Zei, MD, director of the comprehensive atrial fibrillation program at Brigham and Women’s Hospital, explained key findings from the late-breaking REAL-AF Registry at the Heart Rhythm Society (HRS) 2024 conference. This registry study evaluated the short- and long-term outcomes of radiofrequency ablation (RF) in treating both paroxysmal atrial fibrillation (PAF) and persistent atrial fibrillation (PsAF), revealing significant advancements in procedural techniques and patient safety. #EPeeps #HRS2024

Interest growing in fluoroscopy-free workflows during RF ablation

Paul Zei, MD, discusses late-breaking data from the REAL-AF Registry, which looked at the short- and long-term outcomes of radiofrequency ablation in paroxysmal and persistent atrial fibrillation.

doctor examines patient data on their tablet

Engineers team with cardiologist to rethink heart pump assessments

The group’s work is focused on how signal processing technologies and machine learning can track the health of VADs and the patients who need them. 

The rapid rise of artificial intelligence (AI) has helped cardiologists, radiologists, nurses and other healthcare providers embrace precision medicine in a way that ensures more heart patients are receiving personalized care.

AI uses imaging results to ID high-risk TAVR patients with speed, accuracy

Researchers developed an advanced AI model capable of extracting measurements from unprocessed CT images in seconds. It then uses those data to evaluate the patient's mortality risk if they underwent TAVR.

Video interview with Devi Nair, MD, who shares her experience of using the Sphere-9 PFA system in the FDA IDE late-breaking trial at HRS24. #HRS #PFA #HRS2024

All-in-one PFA system linked to positive safety profile, faster procedures

Devi Nair, MD, director of cardiac electrophysiology with St. Bernard's Heart and Vascular Center, discussed her experience using a new-look Medtronic pulsed field ablation (PFA) system to treat persistent AFib.

The late-breaking U.S. multicenter admIRE clinical trial at the Heart Rhythm Society 2024 meeting, showed positive data on the long-term safety and effectiveness of the the Biosense Webster Varipulse pulsed field ablation (PFA) system in patients with paroxysmal atrial fibrillation. #HRS #HRS2024 #PFA

Biosense Webster Varipulse PFA system performs well with minimal adverse events

"This was the first PFA IDE study to support a substantial number of fluoro-free procedures," said presenter Vivek Reddy, MD.

The EuroPCR 2024 meeting May 14-17 in Paris included four days of late-breaking interventional cardiology science presentations featured 12,100 participants, more than 550 educational sessions and 12 live cases. Photo courtesy of EuroPCR

5 takeaways from late-breaking studies at EuroPCR

The Society for Cardiovascular Angiography and Interventions offers its top five key takeaways from the EuroPCR 2024 meeting last week.

Around the web

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.

Trimed Popup
Trimed Popup